| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.0B | $2.1B | $2.3B | $2.4B | $2.0B | $0.6B | $0.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.4B | $0.4B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.7B | $0.5B | $0.7B | $1.1B | $0.6B | $0.2B | $0.0B | $-0.2B |
| EPS (Basic) | $25.18 | $16.45 | $19.18 | $29.77 | $13.65 | $4.34 | $0.31 | $4.55 |
| EPS (Diluted) | $22.74 | $15.13 | $17.42 | $25.35 | $13.05 | $4.33 | $0.46 | $-2.88 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.2B | $8.8B | $9.1B | $8.9B | $8.9B | $7.9B | $7.7B | $8.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.6B | $0.9B | $0.8B | $0.4B | $0.9B | $1.0B | $0.5B | $0.6B |
| Total Liabilities | $4.8B | $4.2B | $4.1B | $4.2B | $4.5B | $3.9B | $3.2B | $3.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.2B | $3.3B | $3.6B | $3.2B | $2.8B | $2.8B | $2.9B | $3.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.9B | $0.9B | $1.1B | $1.3B | $1.0B | $0.9B | $1.1B |
| Investing Cash Flow | $-0.2B | $0.4B | $0.3B | $-0.1B | $-0.6B | $-0.1B | $-0.0B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-1.1B | $-1.2B | $-0.8B | $-1.4B | $-0.8B | $-0.5B | $-0.9B | $-1.0B |